Status: Recruiting
A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients
BEAT-BK will see the effect of immunosuppression reduction/modification with and without IVIG on BKPyV infection, allograft function, allograft loss, acute transplant rejection, immunosuppression load and death in kidney and simultaneous kidney pancreas transplant recipients with polyomavirus infections (BKPyV).
Participants needed: 280
Trial details
Phase: Phase 3Age: 2+Biological sex: AllType: InterventionalSponsor: The University of QueenslandUpdated: Jun 8, 2026Locations: 13
Eligibility criteria
Aged 2 years or above [+3]
Contraindications to receiving IVIG as a treatment [+7]